ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill

May 9, 2014

Ronald DePinho Apologizes, Takes Responsibility For “Morale Issues” at MD Anderson

September 27, 2013

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

June 24, 2011

Half-Percent NIH, NCI Budget Raise Is Not Enough, Advocates Say

December 19, 2014

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Congress Reaffirms GRH FY 1986 Cuts

July 25, 1986